Airways, pathogens, innate immunity
11 – 20 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
(
- Contribution to journal › Article
-
Mark
Genomic and phenotypic evolution of achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis
(
- Contribution to journal › Article
-
Mark
Complex Involvement of Interleukin-26 in Bacterial Lung Infection
(
- Contribution to journal › Article
- 2020
-
Mark
Activity of airway antimicrobial peptides against cystic fibrosis pathogens
(
- Contribution to journal › Article
-
Mark
Morbidity and mortality in critically ill patients with invasive group A streptococcus infection : an observational study
(
- Contribution to journal › Article
-
Mark
Commercial albumin solution enhances endotoxin-induced vasoplegia and inflammation
(
- Contribution to journal › Article
-
Mark
Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
(
- Contribution to journal › Article
-
Mark
Risk of bacteremia in patients presenting with shaking chills and vomiting - A prospective cohort study
(
- Contribution to journal › Article
-
Mark
BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization
(
- Contribution to journal › Article
-
Mark
Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
(
- Contribution to journal › Article